Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Hepatocellular Carcinoma|October 1, 2021
Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular CarcinomaBetul Gok Yavuz, Elshad Hasanov, Sunyoung S Lee, et al.
Journal of Hepatocellular Carcinoma|September 6, 2022
The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus BevacizumabMuhammad O Awiwi, Khaled M Elsayes, Yehia I Mohamed, et al.
Pathogens (Basel, Switzerland)|April 3, 2021
The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 InfectionAhmed O Kaseb, Yehia I Mohamed, Alexandre E Malek, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cellsLi Gu, Yahui Zhu, Maiya Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2023
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cellsLi Gu, Yahui Zhu, Maiya Lee, et al.
Journal of Hepatocellular Carcinoma|March 11, 2024
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular CarcinomaShadi Chamseddine, Michael LaPelusa, Lianchun Xiao, et al.
Frontiers in Pharmacology|February 21, 2024
Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infectionAbdelrahim Maen, Betul Gok Yavuz, Yehia I Mohamed, et al.
Frontiers in Oncology|October 24, 2022
Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinomaAhmed O Kaseb, Abedul Haque, Deeksha Vishwamitra, et al.
Cancers|October 14, 2023
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular CarcinomaBetul Gok Yavuz, Saumil Datar, Shadi Chamseddine, et al.
Oncotarget|April 23, 2021
Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenibYehia I Mohamed, Sunyoung Lee, Lianchun Xiao, et al.
Pageof 3